IMPORTANT: You must read the following disclaimer before continuing.
PLEASE READ THIS NOTICE CAREFULLY. IT APPLIES TO ALL PERSONS WHO VIEW THIS WEBSITE. VIEWING THIS INFORMATION MAY NOT BE LAWFUL IN CERTAIN JURISDICTIONS. PLEASE NOTE THAT THE DISCLAIMER SET OUT BELOW MAY BE ALTERED OR UPDATED. YOU SHOULD READ IT IN FULL EACH TIME YOU VISIT THE WEBSITE. BY ACCESSING THIS INFORMATION ON THIS WEBSITE, YOU AGREE TO THE TERMS AND CONDITIONS BELOW, INCLUDING ANY MODIFICATIONS THAT MAY BE MADE TO THEM FROM TIME TO TIME.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA AND ARE INTENDED FOR DISTRIBUTION TO, AND USE BY, RESIDENTS OF INDIA ONLY.
THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY WOCKHARDT LIMITED (THE 'COMPANY') SOLELY TO COMPLY WITH THE SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED ('SEBI ICDR REGULATIONS') AND THE COMPANIES ACT, 2013 AND THE RULES MADE THEREUNDER, EACH AS AMENDED ('COMPANIES ACT').
MAKING THE PRELIMINARY PLACEMENT DOCUMENT DATED MARCH 20, 2024 (THE 'PRELIMINARY PLACEMENT DOCUMENT') AVAILABLE IN ELECTRONIC FORMAT ON THIS WEBSITE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY EQUITY SHARES OF THE COMPANY ('EQUITY SHARES') IN THE PROPOSED QUALIFIED INSTITUTIONS PLACEMENT ('ISSUE') IN ANY JURISDICTION.
THIS DISCLAIMER APPLIES TO ALL PERSONS WHO VIEW THIS WEBSITE. THE FOLLOWING DISCLAIMER APPLIES TO THE PRELIMINARY PLACEMENT DOCUMENT IN RELATION TO THE ISSUE OF THE COMPANY FILED WITH BSE LIMITED AND THE NATIONAL STOCK EXCHANGE OF INDIA LIMITED (TOGETHER, THE 'STOCK EXCHANGES'). YOU ARE ADVISED TO READ THIS DISCLAIMER CAREFULLY BEFORE READING, ACCESSING OR MAKING ANY OTHER USE OF THE PRELIMINARY PLACEMENT DOCUMENT.
THE EQUITY SHARES OFFERED IN THE ISSUE HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE 'U.S. SECURITIES ACT'), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES EXCEPT PURSUANT TO A TRANSACTION EXEMPT FROM, OR NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. THE EQUITY SHARES OFFERED IN THE ISSUE ARE BEING OFFERED AND SOLD ONLY OUTSIDE THE UNITED STATES IN 'OFFSHORE TRANSACTIONS' AS DEFINED IN AND IN RELIANCE ON REGULATIONS UNDER THE U.S. SECURITIES ACT.
THE PRELIMINARY PLACEMENT DOCUMENT HAS NOT BEEN AND WILL NOT BE FILED AS A PROSPECTUS OR A STATEMENT IN LIEU OF A PROSPECTUS WITH ANY REGISTRAR OF COMPANIES IN INDIA UNDER THE COMPANIES ACT. THE PRELIMINARY PLACEMENT DOCUMENT HAS BEEN FILED AS A PRIVATE PLACEMENT OFFER LETTER WITH THE STOCK EXCHANGES. THE PRELIMINARY PLACEMENT DOCUMENT IS EXCLUSIVE TO THE RECIPIENT AND IS NOT INTENDED AND DOES NOT CONSTITUTE AN OFFER OR A SOLICITATION OR INVITATION OF AN OFFER TO SUBSCRIBE TO THE SECURITIES DESCRIBED IN THE PRELIMINARY PLACEMENT DOCUMENT TO THE GENERAL PUBLIC OR ANY PERSON OR CLASS OF INVESTORS OTHER THAN ELIGIBLE QUALIFIED INSTITUTIONAL BUYERS, AS DEFINED IN THE SEBI ICDR REGULATIONS. THE PRELIMINARY PLACEMENT DOCUMENT HAS NOT BEEN REVIEWED AND APPROVED BY ANY REGULATORY AUTHORITY IN INDIA OR ABROAD, INCLUDING THE SECURITIES AND EXCHANGE BOARD OF INDIA, THE RESERVE BANK OF INDIA, ANY REGISTRAR OF COMPANIES IN INDIA OR ANY STOCK EXCHANGE IN INDIA. THE PRELIMINARY PLACEMENT DOCUMENT IS NOT AND SHOULD NOT BE CONSTRUED AS AN INVITATION, OFFER OR SALE OF ANY SECURITIES TO THE PUBLIC IN INDIA.
NONE OF THE COMPANY, THE BOOK RUNNING LEAD MANAGER (AS DEFINED IN THE PRELIMINARY PLACEMENT DOCUMENT) AND ANY OF THEIR RESPECTIVE AFFILIATES, ACCEPTS ANY LIABILITY WHATSOEVER, DIRECT OR INDIRECT, THAT MAY ARISE FROM THE USE OF THE INFORMATION CONTAINED ON THIS WEBSITE. ACCESS TO THIS WEBSITE OR THE PRELIMINARY PLACEMENT DOCUMENT DOES NOT CONSTITUTE A RECOMMENDATION BY THE COMPANY, THE BOOK RUNNING LEAD MANAGER, ANY OF THEIR RESPECTIVE AFFILIATES OR ANY OTHER PARTY TO SUBSCRIBE TO OR BUY OR SELL THE EQUITY SHARES OFFERED IN THE ISSUE.
THE PRELIMINARY PLACEMENT DOCUMENT WILL NOT BE CIRCULATED OR DISTRIBUTED TO THE PUBLIC IN INDIA OR ANY OTHER JURISDICTION, AND WILL NOT CONSTITUTE A PUBLIC OFFER IN INDIA OR ANY OTHER JURISDICTION.
THE INFORMATION IN THE PRELIMINARY PLACEMENT DOCUMENT IS AS OF THE DATE THEREOF AND NEITHER THE COMPANY, ITS DIRECTORS NOR THE BOOK RUNNING LEAD MANAGER ARE UNDER ANY OBLIGATION TO UPDATE OR REVISE THE PRELIMINARY PLACEMENT DOCUMENT TO REFLECT CIRCUMSTANCES ARISING AFTER THE DATE THEREOF.
THE ISSUE, AND THE DISTRIBUTION OF THE PRELIMINARY PLACEMENT DOCUMENT IS BEING MADE TO QUALIFIED INSTITUTIONAL BUYERS AS DEFINED UNDER THE SEBI ICDR REGULATIONS ('QIBs') WHICH ARE NOT RESTRICTED FROM PARTICIPATING IN THE ISSUE UNDER THE APPLICABLE LAWS, INCLUDING THE SEBI ICDR REGULATIONS, ARE ELIGIBLE TO INVEST IN THIS ISSUE ('ELIGIBLE QIBs') IN RELIANCE UPON CHAPTER VI OF THE SEBI ICDR REGULATIONS AND SECTIONS 42 AND 62, AND OTHER APPLICABLE PROVISIONS OF THE COMPANIES ACT. UNLESS A SERIALLY NUMBERED PRELIMINARY PLACEMENT DOCUMENT ACCOMPANIED BY AN APPLICATION FORM IS ADDRESSED TO A SPECIFIC QIB INVITING SUCH QIB TO MAKE A BID THROUGH SUCH APPLICATION FORM, NO OFFER AND/OR INVITATION OF OFFER SHALL BE DEEMED TO HAVE BEEN MADE.
YOU ARE ACCESSING THIS WEBSITE AT YOUR OWN RISK AND IT IS YOUR RESPONSIBILITY TO TAKE PRECAUTIONS TO ENSURE THAT IT IS FREE FROM VIRUSES AND OTHER ITEMS OF A DESTRUCTIVE NATURE. NONE OF THE COMPANY, THE BOOK RUNNING LEAD MANAGER OR ANY OF THEIR RESPECTIVE AFFILIATES, DIRECTORS, OFFICERS OR EMPLOYEES WILL BE LIABLE OR HAVE ANY RESPONSIBILITY OF ANY KIND FOR ANY LOSS OR DAMAGE THAT YOU INCUR IN THE EVENT OF ANY FAILURE OR DISRUPTION OF THIS WEBSITE, OR RESULTING FROM THE ACT OR OMISSION OF ANY OTHER PARTY INVOLVED IN MAKING THIS WEBSITE OR THE DATA CONTAINED THEREIN AVAILABLE TO YOU, OR FROM ANY OTHER CAUSE RELATING TO YOUR ACCESS TO, INABILITY TO ACCESS, OR USE OF THE WEBSITE OR THESE MATERIALS. IT IS YOUR RESPONSIBILITY TO TAKE PRECAUTIONS TO ENSURE THAT IT IS FREE FROM VIRUSES AND OTHER ITEMS OF A DESTRUCTIVE NATURE.
THE PRELIMINARY PLACEMENT DOCUMENT MAY NOT BE DISTRIBUTED IN WHOLE OR IN PART, TO ANY OTHER PERSON. FAILURE TO COMPLY WITH THIS DISCLAIMER MAY RESULT IN A VIOLATION OF THE APPLICABLE LAWS.
If you are not in India, please exit this webpage.
By clicking on the “I Confirm” button below you represent to the Company and the Book Running Lead Manager that:
If you cannot make these confirmations, you must press the button marked 'I Do Not Confirm'.
IMPORTANT: You must read the following disclaimer before continuing.
PLEASE READ THIS NOTICE CAREFULLY. IT APPLIES TO ALL PERSONS WHO VIEW THIS WEBSITE. VIEWING THIS INFORMATION MAY NOT BE LAWFUL IN CERTAIN JURISDICTIONS. PLEASE NOTE THAT THE DISCLAIMER SET OUT BELOW MAY BE ALTERED OR UPDATED. YOU SHOULD READ IT IN FULL EACH TIME YOU VISIT THE WEBSITE. BY ACCESSING THIS INFORMATION ON THIS WEBSITE, YOU AGREE TO THE TERMS AND CONDITIONS BELOW, INCLUDING ANY MODIFICATIONS THAT MAY BE MADE TO THEM FROM TIME TO TIME.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA AND ARE INTENDED FOR DISTRIBUTION TO, AND USE BY, RESIDENTS OF INDIA ONLY.
THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY WOCKHARDT LIMITED (THE 'COMPANY') SOLELY TO COMPLY WITH THE SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED (THE 'SEBI ICDR REGULATIONS') AND THE COMPANIES ACT, 2013 AND THE RULES MADE THEREUNDER, EACH AS AMENDED (THE 'COMPANIES ACT').
MAKING THE PLACEMENT DOCUMENT DATED 26 MARCH, 2024 (THE 'PLACEMENT DOCUMENT') AVAILABLE IN ELECTRONIC FORMAT ON THIS WEBSITE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY THE EQUITY SHARES OF THE COMPANY ('EQUITY SHARES') IN THE QUALIFIED INSTITUTIONS PLACEMENT (THE 'ISSUE') IN ANY JURISDICTION.
THIS DISCLAIMER APPLIES TO ALL PERSONS WHO VIEW THIS WEBSITE. THE FOLLOWING DISCLAIMER APPLIES TO THE PLACEMENT DOCUMENT IN RELATION TO THE ISSUE OF THE COMPANY FILED WITH BSE LIMITED AND NATIONAL STOCK EXCHANGE OF INDIA LIMITED (TOGETHER, THE 'STOCK EXCHANGES'). YOU ARE ADVISED TO READ THIS DISCLAIMER CAREFULLY BEFORE READING, ACCESSING OR MAKING ANY OTHER USE OF THE PLACEMENT DOCUMENT.
THE EQUITY SHARES OFFERED IN THE ISSUE HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE 'U.S. SECURITIES ACT'), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES EXCEPT PURSUANT TO A TRANSACTION EXEMPT FROM, OR NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. THE EQUITY SHARES OFFERED IN THE ISSUE ARE BEING OFFERED AND SOLD ONLY OUTSIDE THE UNITED STATES IN 'OFFSHORE TRANSACTIONS' AS DEFINED IN AND IN RELIANCE ON REGULATIONS UNDER THE U.S. SECURITIES ACT.
THE PLACEMENT DOCUMENT HAS NOT BEEN AND WILL NOT BE FILED AS A PROSPECTUS OR A STATEMENT IN LIEU OF A PROSPECTUS WITH ANY REGISTRAR OF COMPANIES IN INDIA UNDER THE COMPANIES ACT. THE PLACEMENT DOCUMENT HAS BEEN FILED AS A PRIVATE PLACEMENT OFFER LETTER WITH THE STOCK EXCHANGES. THE PLACEMENT DOCUMENT IS EXCLUSIVE TO THE RECIPIENT AND IS NOT INTENDED AND DOES NOT CONSTITUTE AN OFFER OR A SOLICITATION OR INVITATION OF AN OFFER TO SUBSCRIBE TO THE SECURITIES DESCRIBED IN THE PLACEMENT DOCUMENT TO THE GENERAL PUBLIC OR ANY PERSON OR CLASS OF INVESTORS OTHER THAN ELIGIBLE QUALIFIED INSTITUTIONAL BUYERS, AS DEFINED IN THE SEBI ICDR REGULATIONS. THE PLACEMENT DOCUMENT HAS NOT BEEN REVIEWED AND APPROVED BY ANY REGULATORY AUTHORITY IN INDIA OR ABROAD, INCLUDING THE SECURITIES AND EXCHANGE BOARD OF INDIA, THE RESERVE BANK OF INDIA, ANY REGISTRAR OF COMPANIES IN INDIA OR ANY STOCK EXCHANGE IN INDIA. THE PLACEMENT DOCUMENT IS NOT AND SHOULD NOT BE CONSTRUED AS AN INVITATION, OFFER OR SALE OF ANY SECURITIES TO THE PUBLIC IN INDIA.
NONE OF THE COMPANY, THE BOOK RUNNING LEAD MANAGER (AS DEFINED IN THE PLACEMENT DOCUMENT) AND ANY OF THEIR RESPECTIVE AFFILIATES, ACCEPTS ANY LIABILITY WHATSOEVER, DIRECT OR INDIRECT, THAT MAY ARISE FROM THE USE OF THE INFORMATION CONTAINED ON THIS WEBSITE. ACCESS TO THIS WEBSITE OR THE PLACEMENT DOCUMENT DOES NOT CONSTITUTE A RECOMMENDATION BY THE COMPANY, THE BOOK RUNNING LEAD MANAGER, ANY OF THEIR RESPECTIVE AFFILIATES OR ANY OTHER PARTY TO SUBSCRIBE TO OR BUY OR SELL THE EQUITY SHARES OFFERED IN THE ISSUE.
THE PLACEMENT DOCUMENT WILL NOT BE CIRCULATED OR DISTRIBUTED TO THE PUBLIC IN INDIA OR ANY OTHER JURISDICTION, AND WILL NOT CONSTITUTE A PUBLIC OFFER IN INDIA OR ANY OTHER JURISDICTION.
THE INFORMATION IN THE PLACEMENT DOCUMENT IS AS OF THE DATE THEREOF AND NEITHER THE COMPANY, ITS DIRECTORS NOR THE BOOK RUNNING LEAD MANAGER ARE UNDER ANY OBLIGATION TO UPDATE OR REVISE THE PLACEMENT DOCUMENT TO REFLECT CIRCUMSTANCES ARISING AFTER THE DATE THEREOF.
THE ISSUE, AND THE DISTRIBUTION OF THE PLACEMENT DOCUMENT IS BEING MADE TO QUALIFIED INSTITUTIONAL BUYERS AS DEFINED UNDER THE SEBI ICDR REGULATIONS ('QIBs') WHICH ARE NOT RESTRICTED FROM PARTICIPATING IN THE ISSUE UNDER THE APPLICABLE LAWS, INCLUDING IN RELIANCE UPON CHAPTER VI OF THE SEBI ICDR REGULATIONS AND SECTIONS 42 AND 62, AND OTHER APPLICABLE PROVISIONS OF THE COMPANIES ACT.
YOU ARE ACCESSING THIS WEBSITE AT YOUR OWN RISK AND IT IS YOUR RESPONSIBILITY TO TAKE PRECAUTIONS TO ENSURE THAT IT IS FREE FROM VIRUSES AND OTHER ITEMS OF A DESTRUCTIVE NATURE. NONE OF THE COMPANY, THE BOOK RUNNING LEAD MANAGER OR ANY OF THEIR RESPECTIVE AFFILIATES, DIRECTORS, OFFICERS OR EMPLOYEES WILL BE LIABLE OR HAVE ANY RESPONSIBILITY OF ANY KIND FOR ANY LOSS OR DAMAGE THAT YOU INCUR IN THE EVENT OF ANY FAILURE OR DISRUPTION OF THIS WEBSITE, OR RESULTING FROM THE ACT OR OMISSION OF ANY OTHER PARTY INVOLVED IN MAKING THIS WEBSITE OR THE DATA CONTAINED THEREIN AND MADE AVAILABLE TO YOU, OR FROM ANY OTHER CAUSE RELATING TO YOUR ACCESS TO, INABILITY TO ACCESS, OR USE OF THE WEBSITE OR THESE MATERIALS. IT IS YOUR RESPONSIBILITY TO TAKE PRECAUTIONS TO ENSURE THAT YOUR ACCESS TO THIS WEBSITE AND THE MATERIALS CONTAINED THEREIN IS FREE FROM VIRUSES AND OTHER ITEMS OF A DESTRUCTIVE NATURE.
THE PLACEMENT DOCUMENT MAY NOT BE DISTRIBUTED IN WHOLE OR IN PART, TO ANY OTHER PERSON. FAILURE TO COMPLY WITH THIS DISCLAIMER MAY RESULT IN A VIOLATION OF THE APPLICABLE LAWS.
If you are not in India, please exit this webpage.
By clicking on the 'I Confirm' button below you represent to the Company and the Book Running Lead Manager that:
If you cannot make these confirmations, you must press the button marked 'I Do Not Confirm'.
IMPORTANT: You must read the following disclaimer before continuing.
PLEASE READ THIS NOTICE CAREFULLY. IT APPLIES TO ALL PERSONS WHO VIEW THIS WEBSITE. VIEWING THIS INFORMATION MAY NOT BE LAWFUL IN CERTAIN JURISDICTIONS. PLEASE NOTE THAT THE DISCLAIMER SET OUT BELOW MAY BE ALTERED OR UPDATED. YOU SHOULD READ IT IN FULL EACH TIME YOU VISIT THE WEBSITE. BY ACCESSING THIS INFORMATION ON THIS WEBSITE, YOU AGREE TO THE TERMS AND CONDITIONS BELOW, INCLUDING ANY MODIFICATIONS THAT MAY BE MADE TO THEM FROM TIME TO TIME.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA AND ARE INTENDED FOR DISTRIBUTION TO, AND USE BY, RESIDENTS OF INDIA ONLY.
THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY WOCKHARDT LIMITED (THE “COMPANY”) SOLELY TO COMPLY WITH THE SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED (THE “SEBI ICDR REGULATIONS”) AND THE COMPANIES ACT, 2013 AND THE RULES MADE THEREUNDER, EACH AS AMENDED (THE “COMPANIES ACT”).
MAKING THE PRELIMINARY PLACEMENT DOCUMENT DATED NOVEMBER 6, 2024 (THE “PRELIMINARY PLACEMENT DOCUMENT”) AVAILABLE IN ELECTRONIC FORMAT ON THIS WEBSITE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY THE EQUITY SHARES OF THE COMPANY (“EQUITY SHARES”) IN THE PROPOSED QUALIFIED INSTITUTIONS PLACEMENT (THE “ISSUE”) IN ANY JURISDICTION.
THIS DISCLAIMER APPLIES TO ALL PERSONS WHO VIEW THIS WEBSITE. THE FOLLOWING DISCLAIMER APPLIES TO THE PRELIMINARY PLACEMENT DOCUMENT IN RELATION TO THE ISSUE OF THE COMPANY FILED WITH BSE LIMITED AND NATIONAL STOCK EXCHANGE OF INDIA LIMITED (TOGETHER, THE “STOCK EXCHANGES”). YOU ARE ADVISED TO READ THIS DISCLAIMER CAREFULLY BEFORE READING, ACCESSING OR MAKING ANY OTHER USE OF THE PRELIMINARY PLACEMENT DOCUMENT.
THE EQUITY SHARES OFFERED IN THE ISSUE HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES EXCEPT PURSUANT TO A TRANSACTION EXEMPT FROM, OR NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. THE EQUITY SHARES OFFERED IN THE ISSUE ARE BEING OFFERED AND SOLD ONLY OUTSIDE THE UNITED STATES IN “OFFSHORE TRANSACTIONS” AS DEFINED IN AND IN RELIANCE ON REGULATION S UNDER THE U.S. SECURITIES ACT.
THE PRELIMINARY PLACEMENT DOCUMENT HAS NOT BEEN AND WILL NOT BE FILED AS A PROSPECTUS OR A STATEMENT IN LIEU OF A PROSPECTUS WITH ANY REGISTRAR OF COMPANIES IN INDIA UNDER THE COMPANIES ACT. THE PRELIMINARY PLACEMENT DOCUMENT HAS BEEN FILED AS A PRIVATE PLACEMENT OFFER LETTER WITH THE STOCK EXCHANGES. THE PRELIMINARY PLACEMENT DOCUMENT IS EXCLUSIVE TO THE RECIPIENT AND IS NOT INTENDED AND DOES NOT CONSTITUTE AN OFFER OR A SOLICITATION OR INVITATION OF AN OFFER TO SUBSCRIBE TO THE SECURITIES DESCRIBED IN THE PRELIMINARY PLACEMENT DOCUMENT TO THE GENERAL PUBLIC OR ANY PERSON OR CLASS OF INVESTORS OTHER THAN ELIGIBLE QUALIFIED INSTITUTIONAL BUYERS, AS DEFINED IN THE SEBI ICDR REGULATIONS. THE PRELIMINARY PLACEMENT DOCUMENT HAS NOT BEEN REVIEWED AND APPROVED BY ANY REGULATORY AUTHORITY IN INDIA OR ABROAD, INCLUDING THE SECURITIES AND EXCHANGE BOARD OF INDIA, THE RESERVE BANK OF INDIA, ANY REGISTRAR OF COMPANIES IN INDIA OR ANY STOCK EXCHANGE IN INDIA. THE PRELIMINARY PLACEMENT DOCUMENT IS NOT AND SHOULD NOT BE CONSTRUED AS AN INVITATION, OFFER OR SALE OF ANY SECURITIES TO THE PUBLIC IN INDIA.
NONE OF THE COMPANY, THE BOOK RUNNING LEAD MANAGER (AS DEFINED IN THE PRELIMINARY PLACEMENT DOCUMENT) AND ANY OF THEIR RESPECTIVE AFFILIATES, ACCEPTS ANY LIABILITY WHATSOEVER, DIRECT OR INDIRECT, THAT MAY ARISE FROM THE USE OF THE INFORMATION CONTAINED ON THIS WEBSITE. ACCESS TO THIS WEBSITE OR THE PRELIMINARY PLACEMENT DOCUMENT DOES NOT CONSTITUTE A RECOMMENDATION BY THE COMPANY, THE BOOK RUNNING LEAD MANAGER, ANY OF THEIR RESPECTIVE AFFILIATES OR ANY OTHER PARTY TO SUBSCRIBE TO OR BUY OR SELL THE EQUITY SHARES OFFERED IN THE ISSUE.
THE PRELIMINARY PLACEMENT DOCUMENT WILL NOT BE CIRCULATED OR DISTRIBUTED TO THE PUBLIC IN INDIA OR ANY OTHER JURISDICTION, AND WILL NOT CONSTITUTE A PUBLIC OFFER IN INDIA OR ANY OTHER JURISDICTION.
THE INFORMATION IN THE PRELIMINARY PLACEMENT DOCUMENT IS AS OF THE DATE THEREOF AND NEITHER THE COMPANY, ITS DIRECTORS NOR THE BOOK RUNNING LEAD MANAGER ARE UNDER ANY OBLIGATION TO UPDATE OR REVISE THE PRELIMINARY PLACEMENT DOCUMENT TO REFLECT CIRCUMSTANCES ARISING AFTER THE DATE THEREOF.
THE ISSUE, AND THE DISTRIBUTION OF THE PRELIMINARY PLACEMENT DOCUMENT IS BEING MADE TO QUALIFIED INSTITUTIONAL BUYERS AS DEFINED UNDER THE SEBI ICDR REGULATIONS (“QIBs”) WHICH ARE NOT RESTRICTED FROM PARTICIPATING IN THE ISSUE UNDER THE APPLICABLE LAWS, INCLUDING IN RELIANCE UPON CHAPTER VI OF THE SEBI ICDR REGULATIONS AND SECTIONS 42 AND 62, AND OTHER APPLICABLE PROVISIONS OF THE COMPANIES ACT. UNLESS A SERIALLY NUMBERED PRELIMINARY PLACEMENT DOCUMENT ACCOMPANIED BY AN APPLICATION FORM IS ADDRESSED TO A SPECIFIC QIB INVITING SUCH QIB TO MAKE A BID THROUGH SUCH APPLICATION FORM, NO OFFER AND/OR INVITATION OF OFFER SHALL BE DEEMED TO HAVE BEEN MADE.
YOU ARE ACCESSING THIS WEBSITE AT YOUR OWN RISK AND IT IS YOUR RESPONSIBILITY TO TAKE PRECAUTIONS TO ENSURE THAT IT IS FREE FROM VIRUSES AND OTHER ITEMS OF A DESTRUCTIVE NATURE. NONE OF THE COMPANY, THE BOOK RUNNING LEAD MANAGER OR ANY OF THEIR RESPECTIVE AFFILIATES, DIRECTORS, OFFICERS OR EMPLOYEES WILL BE LIABLE OR HAVE ANY RESPONSIBILITY OF ANY KIND FOR ANY LOSS OR DAMAGE THAT YOU INCUR IN THE EVENT OF ANY FAILURE OR DISRUPTION OF THIS WEBSITE, OR RESULTING FROM THE ACT OR OMISSION OF ANY OTHER PARTY INVOLVED IN MAKING THIS WEBSITE OR THE DATA CONTAINED THEREIN AND MADE AVAILABLE TO YOU, OR FROM ANY OTHER CAUSE RELATING TO YOUR ACCESS TO, INABILITY TO ACCESS, OR USE OF THE WEBSITE OR THESE MATERIALS. IT IS YOUR RESPONSIBILITY TO TAKE PRECAUTIONS TO ENSURE THAT YOUR ACCESS TO THIS WEBSITE AND THE MATERIALS CONTAINED THEREIN IS FREE FROM VIRUSES AND OTHER ITEMS OF A DESTRUCTIVE NATURE.
THE PRELIMINARY PLACEMENT DOCUMENT MAY NOT BE DISTRIBUTED IN WHOLE OR IN PART, TO ANY OTHER PERSON. FAILURE TO COMPLY WITH THIS DISCLAIMER MAY RESULT IN A VIOLATION OF THE APPLICABLE LAWS.
If you are not in India, please exit this webpage.
By clicking on the “I Confirm” button below you represent to the Company and the Book Running Lead Manager that:
If you cannot make these confirmations, you must press the button marked “I Do Not Confirm”.
IMPORTANT: You must read the following disclaimer before continuing.
PLEASE READ THIS NOTICE CAREFULLY. IT APPLIES TO ALL PERSONS WHO VIEW THIS WEBSITE. VIEWING THIS INFORMATION MAY NOT BE LAWFUL IN CERTAIN JURISDICTIONS. PLEASE NOTE THAT THE DISCLAIMER SET OUT BELOW MAY BE ALTERED OR UPDATED. YOU SHOULD READ IT IN FULL EACH TIME YOU VISIT THE WEBSITE. BY ACCESSING THIS INFORMATION ON THIS WEBSITE, YOU AGREE TO THE TERMS AND CONDITIONS BELOW, INCLUDING ANY MODIFICATIONS THAT MAY BE MADE TO THEM FROM TIME TO TIME.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA AND ARE INTENDED FOR DISTRIBUTION TO, AND USE BY, RESIDENTS OF INDIA ONLY.
THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY WOCKHARDT LIMITED (THE “COMPANY”) SOLELY TO COMPLY WITH THE SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED (THE “SEBI ICDR REGULATIONS”) AND THE COMPANIES ACT, 2013 AND THE RULES MADE THEREUNDER, EACH AS AMENDED (THE “COMPANIES ACT”).
MAKING THE PLACEMENT DOCUMENT DATED NOVEMBER 6, 2024 (THE “PLACEMENT DOCUMENT”) AVAILABLE IN ELECTRONIC FORMAT ON THIS WEBSITE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY THE EQUITY SHARES OF THE COMPANY (“EQUITY SHARES”) IN THE PROPOSED QUALIFIED INSTITUTIONS PLACEMENT (THE “ISSUE”) IN ANY JURISDICTION.
THIS DISCLAIMER APPLIES TO ALL PERSONS WHO VIEW THIS WEBSITE. THE FOLLOWING DISCLAIMER APPLIES TO THE PLACEMENT DOCUMENT IN RELATION TO THE ISSUE OF THE COMPANY FILED WITH BSE LIMITED AND NATIONAL STOCK EXCHANGE OF INDIA LIMITED (TOGETHER, THE “STOCK EXCHANGES”). YOU ARE ADVISED TO READ THIS DISCLAIMER CAREFULLY BEFORE READING, ACCESSING OR MAKING ANY OTHER USE OF THE PLACEMENT DOCUMENT.
THE EQUITY SHARES OFFERED IN THE ISSUE HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES EXCEPT PURSUANT TO A TRANSACTION EXEMPT FROM, OR NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. THE EQUITY SHARES OFFERED IN THE ISSUE ARE BEING OFFERED AND SOLD ONLY OUTSIDE THE UNITED STATES IN “OFFSHORE TRANSACTIONS” AS DEFINED IN AND IN RELIANCE ON REGULATION S UNDER THE U.S. SECURITIES ACT.
THE PLACEMENT DOCUMENT HAS NOT BEEN AND WILL NOT BE FILED AS A PROSPECTUS OR A STATEMENT IN LIEU OF A PROSPECTUS WITH ANY REGISTRAR OF COMPANIES IN INDIA UNDER THE COMPANIES ACT. THE PLACEMENT DOCUMENT HAS BEEN FILED AS A PRIVATE PLACEMENT OFFER LETTER WITH THE STOCK EXCHANGES. THE PLACEMENT DOCUMENT IS EXCLUSIVE TO THE RECIPIENT AND IS NOT INTENDED AND DOES NOT CONSTITUTE AN OFFER OR A SOLICITATION OR INVITATION OF AN OFFER TO SUBSCRIBE TO THE SECURITIES DESCRIBED IN THE PLACEMENT DOCUMENT TO THE GENERAL PUBLIC OR ANY PERSON OR CLASS OF INVESTORS OTHER THAN ELIGIBLE QUALIFIED INSTITUTIONAL BUYERS, AS DEFINED IN THE SEBI ICDR REGULATIONS. THE PLACEMENT DOCUMENT HAS NOT BEEN REVIEWED AND APPROVED BY ANY REGULATORY AUTHORITY IN INDIA OR ABROAD, INCLUDING THE SECURITIES AND EXCHANGE BOARD OF INDIA, THE RESERVE BANK OF INDIA, ANY REGISTRAR OF COMPANIES IN INDIA OR ANY STOCK EXCHANGE IN INDIA. THE PLACEMENT DOCUMENT IS NOT AND SHOULD NOT BE CONSTRUED AS AN INVITATION, OFFER OR SALE OF ANY SECURITIES TO THE PUBLIC IN INDIA.
NONE OF THE COMPANY, THE BOOK RUNNING LEAD MANAGER (AS DEFINED IN THE PLACEMENT DOCUMENT) AND ANY OF THEIR RESPECTIVE AFFILIATES, ACCEPTS ANY LIABILITY WHATSOEVER, DIRECT OR INDIRECT, THAT MAY ARISE FROM THE USE OF THE INFORMATION CONTAINED ON THIS WEBSITE. ACCESS TO THIS WEBSITE OR THE PLACEMENT DOCUMENT DOES NOT CONSTITUTE A RECOMMENDATION BY THE COMPANY, THE BOOK RUNNING LEAD MANAGER, ANY OF THEIR RESPECTIVE AFFILIATES OR ANY OTHER PARTY TO SUBSCRIBE TO OR BUY OR SELL THE EQUITY SHARES OFFERED IN THE ISSUE.
THE PLACEMENT DOCUMENT WILL NOT BE CIRCULATED OR DISTRIBUTED TO THE PUBLIC IN INDIA OR ANY OTHER JURISDICTION, AND WILL NOT CONSTITUTE A PUBLIC OFFER IN INDIA OR ANY OTHER JURISDICTION.
THE INFORMATION IN THE PLACEMENT DOCUMENT IS AS OF THE DATE THEREOF AND NEITHER THE COMPANY, ITS DIRECTORS NOR THE BOOK RUNNING LEAD MANAGER ARE UNDER ANY OBLIGATION TO UPDATE OR REVISE THE PLACEMENT DOCUMENT TO REFLECT CIRCUMSTANCES ARISING AFTER THE DATE THEREOF.
THE ISSUE, AND THE DISTRIBUTION OF THE PLACEMENT DOCUMENT IS BEING MADE TO QUALIFIED INSTITUTIONAL BUYERS AS DEFINED UNDER THE SEBI ICDR REGULATIONS (“QIBs”) WHICH ARE NOT RESTRICTED FROM PARTICIPATING IN THE ISSUE UNDER THE APPLICABLE LAWS, INCLUDING IN RELIANCE UPON CHAPTER VI OF THE SEBI ICDR REGULATIONS AND SECTIONS 42 AND 62, AND OTHER APPLICABLE PROVISIONS OF THE COMPANIES ACT. UNLESS A SERIALLY NUMBERED PLACEMENT DOCUMENT ACCOMPANIED BY AN APPLICATION FORM IS ADDRESSED TO A SPECIFIC QIB INVITING SUCH QIB TO MAKE A BID THROUGH SUCH APPLICATION FORM, NO OFFER AND/OR INVITATION OF OFFER SHALL BE DEEMED TO HAVE BEEN MADE.
YOU ARE ACCESSING THIS WEBSITE AT YOUR OWN RISK AND IT IS YOUR RESPONSIBILITY TO TAKE PRECAUTIONS TO ENSURE THAT IT IS FREE FROM VIRUSES AND OTHER ITEMS OF A DESTRUCTIVE NATURE. NONE OF THE COMPANY, THE BOOK RUNNING LEAD MANAGER OR ANY OF THEIR RESPECTIVE AFFILIATES, DIRECTORS, OFFICERS OR EMPLOYEES WILL BE LIABLE OR HAVE ANY RESPONSIBILITY OF ANY KIND FOR ANY LOSS OR DAMAGE THAT YOU INCUR IN THE EVENT OF ANY FAILURE OR DISRUPTION OF THIS WEBSITE, OR RESULTING FROM THE ACT OR OMISSION OF ANY OTHER PARTY INVOLVED IN MAKING THIS WEBSITE OR THE DATA CONTAINED THEREIN AND MADE AVAILABLE TO YOU, OR FROM ANY OTHER CAUSE RELATING TO YOUR ACCESS TO, INABILITY TO ACCESS, OR USE OF THE WEBSITE OR THESE MATERIALS. IT IS YOUR RESPONSIBILITY TO TAKE PRECAUTIONS TO ENSURE THAT YOUR ACCESS TO THIS WEBSITE AND THE MATERIALS CONTAINED THEREIN IS FREE FROM VIRUSES AND OTHER ITEMS OF A DESTRUCTIVE NATURE.
THE PLACEMENT DOCUMENT MAY NOT BE DISTRIBUTED IN WHOLE OR IN PART, TO ANY OTHER PERSON. FAILURE TO COMPLY WITH THIS DISCLAIMER MAY RESULT IN A VIOLATION OF THE APPLICABLE LAWS.
If you are not in India, please exit this webpage.
By clicking on the “I Confirm” button below you represent to the Company and the Book Running Lead Manager that:
If you cannot make these confirmations, you must press the button marked “I Do Not Confirm”.
Product Name<\/th>\n | Formulation<\/th>\n | Strength<\/th>\n | Pack Size<\/th>\n | Product Classification<\/th>\n<\/tr>\n<\/thead>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abiraterone <\/td>\n | Tablets<\/td>\n | 500mg<\/td>\n | 56 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aciclovir <\/td>\n | Tablets<\/td>\n | 200mg<\/td>\n | 25 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aciclovir <\/td>\n | Tablets<\/td>\n | 400mg<\/td>\n | 56 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aciclovir <\/td>\n | Tablets<\/td>\n | 800mg<\/td>\n | 35 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aciclovir powder for injection<\/td>\n | Vials<\/td>\n | 250mg<\/td>\n | 5<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adenosine Injection <\/td>\n | Vials<\/td>\n | 6mg\/2ml<\/td>\n | 6<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adenosine Injection <\/td>\n | Vials<\/td>\n | 30mg\/10ml<\/td>\n | 6<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allergy Hayfever relief<\/td>\n | Tablets<\/td>\n | 10mg<\/td>\n | 12 x 14 Bli.Pack<\/td>\n | GSL Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allergy Hayfever relief<\/td>\n | Tablets<\/td>\n | 10mg<\/td>\n | 10 x 30 Bli.Pack <\/td>\n | GSL Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amiloride<\/td>\n | Tablets<\/td>\n | 5mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amitriptyline<\/span> (Sugar Free)<\/span><\/td>\n | oral solution<\/td>\n | 10mg\/5ml<\/td>\n | 150ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amitriptyline <\/span>(Sugar Free)<\/span><\/td>\n | oral solution<\/td>\n | 25mg\/5ml<\/td>\n | 150ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amitriptyline <\/span>(Sugar Free)<\/span><\/td>\n | oral solution<\/td>\n | 50mg\/5ml<\/td>\n | 150ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amoxicillin Injection<\/td>\n | Vials<\/td>\n | 250mg<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amoxicillin Injection<\/td>\n | Vials<\/td>\n | 500mg<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amoxicillin Injection<\/td>\n | Vial<\/td>\n | 1g <\/td>\n | 1<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anidulafungin Powder for concentrate for solution for infusion<\/b><\/td>\n | Vial<\/td>\n | 100mg<\/td>\n | 1<\/td>\n | POM Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aspirin <\/span>(gastro resistant)<\/span><\/td>\n | Tablets<\/td>\n | 75mg<\/td>\n | 28 Bli Pack <\/td>\n | GSL Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aspirin <\/span>(gastro-resistant)<\/span><\/td>\n | Tablets<\/td>\n | 75mg<\/td>\n | 56 Bli.Pack<\/td>\n | OTC (P) Generics<\/td>\n <\/tr>\n | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Budesonide\/formoterol (branded as WockAIR\u00ae<\/sup>)<\/b><\/td>\n Inhalation device<\/td>\n | 160mcg\/4.5mcg<\/td>\n | 120 dose (2 x 60 dose inhaler multipack)<\/td>\n | POM Retail Brands<\/td>\n <\/tr>\n | Budesonide\/formoterol (branded as WockAIR\u00ae<\/sup>)<\/b><\/td>\n | Inhalation device<\/td>\n | 320mcg\/9mcg<\/td>\n | 60 dose (1 x 60 dose inhaler)<\/td>\n | POM Retail Brands<\/td>\n <\/tr>\n | Captopril<\/td>\n | Oral Solution (sugar-free)<\/td>\n | 5mg\/5ml<\/td>\n | 1 bottle (100ml)<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Captopril<\/td>\n | Oral Solution (sugar-free)<\/td>\n | 25mg\/5ml<\/td>\n | 1 bottle (100ml)<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Caspofungin<\/td>\n | Vial<\/td>\n | 50mg<\/td>\n | 1<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Caspofungin<\/td>\n | Vial<\/td>\n | 70mg<\/td>\n | 1<\/td>\n | POM Generics<\/td>\n <\/tr>\n | CefoTAXime Injection<\/td>\n | Vials<\/td>\n | 500mg<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | CefoTAXime Injection<\/td>\n | Vials<\/td>\n | 1g<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | CeftAZIDime Injection<\/td>\n | Vials<\/td>\n | 1g<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | CeftAZIDime Injection<\/td>\n | Vials<\/td>\n | 2g<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | CefTRIAXone Injection<\/td>\n | Vials<\/td>\n | 1g<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | CefTRIAXone Injection <\/td>\n | Vials<\/td>\n | 2g<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Chlorphenamine Injection <\/td>\n | Ampoules<\/td>\n | 10mg\/ml<\/td>\n | 5 x 1ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Clobazam <\/span>(sugar free)<\/span><\/td>\n | Oral suspension<\/td>\n | 2mg\/ml<\/td>\n | 150ml Bottle <\/td>\n | POM Generics<\/td>\n <\/tr>\n | Clomifene<\/td>\n | Tablets<\/td>\n | 50mg<\/td>\n | 30 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Co-AmilofRUSE<\/td>\n | Tablets<\/td>\n | 2.5\/20mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Co-AmilofRUSE<\/td>\n | Tablets<\/td>\n | 5\/40mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Co-AmiloZIDE<\/td>\n | Tablets<\/td>\n | 2.5\/25mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Co-AmiloZIDE<\/td>\n | Tablets<\/td>\n | 5\/50mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Co-Amoxiclav Injection<\/td>\n | Vials<\/td>\n | 600mg<\/td>\n | 10 x 600mg<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Co-Amoxiclav Injection<\/td>\n | Vials<\/td>\n | 1.2g<\/td>\n | 10 x 1.2g<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Co-Codamol<\/td>\n | Tablets<\/td>\n | 30\/500mg<\/td>\n | 30 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Co-Codamol<\/td>\n | Tablets<\/td>\n | 30\/500mg<\/td>\n | 100 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Co-Codamol<\/td>\n | Caplets <\/td>\n | 30\/500mg<\/td>\n | 100 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Co-Codamol<\/td>\n | Caplets <\/td>\n | 8\/500mg<\/td>\n | 32 Bli.Pack<\/td>\n | OTC (P) Generics<\/td>\n <\/tr>\n | Codeine Phosphate<\/td>\n | Tablets<\/td>\n | 15mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Codeine Phosphate<\/td>\n | Tablets<\/td>\n | 30mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Colchicine<\/td>\n | Tablets<\/td>\n | 500mcg<\/td>\n | 100 Pot<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Co-Tenidone<\/td>\n | Tablets<\/td>\n | 50\/12.5mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Co-Tenidone<\/td>\n | Tablets<\/td>\n | 100\/25mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Daptomycin Powder for injection<\/td>\n | Vial<\/td>\n | 350mg<\/td>\n | 1<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Daptomycin Powder for injection<\/td>\n | Vial<\/td>\n | 500mg<\/td>\n | 1<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Dexamethasone Injection<\/td>\n | Ampoules<\/td>\n | 3.3mg\/ml<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Diamorphine Injection<\/td>\n | Ampoules BP<\/td>\n | 5mg<\/td>\n | 5 Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Diamorphine Injection<\/td>\n | Ampoules BP<\/td>\n | 10mg<\/td>\n | 5 Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Diamorphine Injection<\/td>\n | Ampoules BP<\/td>\n | 30mg<\/td>\n | 5 Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Diamorphine Injection<\/td>\n | Ampoules BP<\/td>\n | 100mg<\/td>\n | 5 Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Dimethyl Fumarate<\/td>\n | Hard capsules<\/td>\n | 120mg<\/td>\n | 14 pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Dimethyl Fumarate<\/td>\n | Hard capsules<\/td>\n | 240mg<\/td>\n | 56 pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Dual action pain control <\/td>\n | Caplets <\/td>\n | –<\/td>\n | 12 x 16 Bli Pack<\/td>\n | GSL Generics<\/td>\n <\/tr>\n | Ephedrine Hydrochloride<\/td>\n | Tablets<\/td>\n | 15mg<\/td>\n | 28 Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Ephedrine Hydrochloride<\/td>\n | Tablets<\/td>\n | 30mg<\/td>\n | 28 Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Ferrous Sulphate <\/td>\n | Tablets<\/td>\n | 200mg<\/td>\n | 28 Bli.Pack<\/td>\n | OTC (P) Generics<\/td>\n <\/tr>\n | Ferrous Sulphate <\/td>\n | Tablets<\/td>\n | 200mg<\/td>\n | 100 Bli.Pack<\/td>\n | OTC (P) Generics<\/td>\n <\/tr>\n | Flucloxacillin Injection<\/td>\n | Vials<\/td>\n | 250mg<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Flucloxacillin Injection<\/td>\n | Vials<\/td>\n | 500mg<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Flucloxacillin Injection<\/td>\n | Vials<\/td>\n | 1g<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Folic Acid<\/td>\n | Tablets<\/td>\n | 5mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Folic Acid – sugar free<\/td>\n | Oral solution<\/td>\n | 2.5mg\/5ml<\/td>\n | 150ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Gentamicin Injection<\/td>\n | Ampoules<\/td>\n | 10mg\/ml (20mg in 2ml)<\/td>\n | 5 x 2ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Gentamicin Injection<\/td>\n | Ampoules<\/td>\n | 40mg\/ml (80mg in 2ml)<\/td>\n | 5 x 2ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Heparin Calcium <\/span>(preservative free) <\/span><\/td>\n | Ampoules<\/td>\n | 5000 I.U.\/0.2ml<\/td>\n | 10 x 0.2ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Heparin Sodium <\/span>(contains preservative) <\/span><\/td>\n | Vials<\/td>\n | 1000 I.U.\/ml<\/td>\n | 10 x 5ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Heparin Sodium <\/span>(contains preservative) <\/span><\/td>\n | Vials<\/td>\n | 5000 I.U.\/ml<\/td>\n | 10 x 5ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Heparin Sodium <\/span>(preservative free) <\/span><\/td>\n | Ampoules<\/td>\n | 1000 I.U.\/ml<\/td>\n | 10 x 1ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Heparin Sodium <\/span>(preservative free) <\/span><\/td>\n | Ampoules<\/td>\n | 1000 I.U.\/ml<\/td>\n | 10 x 5ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Heparin Sodium <\/span>(preservative free) <\/span><\/td>\n | Ampoules<\/td>\n | 1000 I.U.\/ml<\/td>\n | 10 x 10ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Heparin Sodium <\/span>(preservative free) <\/span><\/td>\n | Ampoules<\/td>\n | 1000 I.U.\/ml<\/td>\n | 10 x 20ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Heparin Sodium <\/span>(preservative free) <\/span><\/td>\n | Ampoules<\/td>\n | 5000 I.U.\/ml<\/td>\n | 10 x 1ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Heparin Sodium <\/span>(preservative free) <\/span><\/td>\n | Ampoules<\/td>\n | 5000 I.U.\/ml<\/td>\n | 10 x 5ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Heparin Sodium <\/span>(preservative free) <\/span><\/td>\n | Ampoules<\/td>\n | 25000 I.U.\/ml<\/td>\n | 10 x 1ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Heparin Sodium <\/span>(preservative free) <\/span><\/td>\n | Ampoules<\/td>\n | 5000 I.U.\/0.2ml<\/td>\n | 10 x 0.2ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Heparin Sodium Flushing Solution <\/span>(preservative free) <\/span> <\/span><\/td>\n | Ampoules<\/td>\n | 100 I.U.\/ml<\/td>\n | 10 x 2ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Heparin Sodium Flushing Solution <\/span>(preservative free) <\/span><\/td>\n | Ampoules<\/td>\n | 10 I.U.\/ml<\/td>\n | 10 x 5ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Hyaluronidase <\/span> <\/span><\/td>\n | Ampoules<\/td>\n | 1500i.u.<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Hypurin\u00ae<\/sup> <\/span>Porcine 30\/70 Mix Insulin<\/span><\/td>\n | Vial<\/td>\n | 100 units per ml<\/td>\n | 10ml<\/td>\n | POM brands<\/td>\n <\/tr>\n | Hypurin\u00ae<\/sup> <\/span>Porcine 30\/70 Mix Insulin<\/span><\/td>\n | Cartridges<\/td>\n | 100 units per ml<\/td>\n | 5 x 3ml<\/td>\n | POM brands<\/td>\n <\/tr>\n | Hypurin\u00ae<\/sup> <\/span>Porcine Isophane Insulin<\/span><\/td>\n | Vial<\/td>\n | 100 units per ml<\/td>\n | 10ml<\/td>\n | POM brands<\/td>\n <\/tr>\n | Hypurin\u00ae<\/sup> <\/span>Porcine Isophane Insulin<\/span><\/td>\n | Cartridges<\/td>\n | 100 units per ml<\/td>\n | 5 x 3ml<\/td>\n | POM brands<\/td>\n <\/tr>\n | Hypurin\u00ae<\/sup> <\/span>Porcine Neutral Insulin<\/span><\/td>\n | Vial<\/td>\n | 100 units per ml<\/td>\n | 10ml<\/td>\n | POM brands<\/td>\n <\/tr>\n | Hypurin\u00ae<\/sup> <\/span>Porcine Neutral Insulin<\/span><\/td>\n | Cartridges<\/td>\n | 100 units per ml<\/td>\n | 5 x 3ml<\/td>\n | POM brands<\/td>\n <\/tr>\n | Ibuprofen<\/td>\n | Tablets<\/td>\n | 200mg<\/td>\n | 12×16 Bli Pack<\/td>\n | GSL Generics<\/td>\n <\/tr>\n | Ibuprofen<\/td>\n | caplets<\/td>\n | 200mg<\/td>\n | 12×16 Bli Pack<\/td>\n | GSL Generics<\/td>\n <\/tr>\n | Ibuprofen <\/td>\n | Tablets<\/td>\n | 400mg<\/td>\n | 84 Bli Pack<\/td>\n | OTC (P) Generics<\/td>\n <\/tr>\n | Icatibant Injection<\/td>\n | Pre-filled syringe<\/td>\n | 30mg in 3ml<\/td>\n | 1 x pre-filled syringe<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Levetiracetam Injection <\/td>\n | Vials<\/td>\n | 100mg\/ml<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Levomepromazine Injection<\/td>\n | Ampoules<\/td>\n | 25mg\/ml<\/td>\n | 10 x 1ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Levothyroxine<\/td>\n | Tablets<\/td>\n | 25mcg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Metaraminol<\/td>\n | Ampoules<\/td>\n | 10mg\/ml<\/td>\n | 10 x 1ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Milrinone<\/td>\n | Ampoules<\/td>\n | 1mg\/ml<\/td>\n | 10 x 10ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Micafungin powder for concentrate for solution for infusion<\/td>\n | Vial<\/td>\n | 50mg<\/td>\n | 1 vial<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Micafungin powder for concentrate for solution for infusion<\/td>\n | Vial<\/td>\n | 100mg<\/td>\n | 1 vial<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Morphine Sulphate Injection<\/td>\n | Ampoules<\/td>\n | 30mg\/ml<\/td>\n | 5 x 2ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Morphine Sulphate <\/span>(Contains Sugar) <\/span><\/td>\n | Oral Solution <\/td>\n | 10mg\/5ml<\/td>\n | 100ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Morphine Sulphate <\/span>(Contains Sugar) <\/span><\/td>\n | Oral Solution <\/td>\n | 10mg\/5ml<\/td>\n | 300ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Morphine Sulphate <\/span>(Contains Sugar) <\/span><\/td>\n | Oral Solution <\/td>\n | 10mg\/5ml<\/td>\n | 500ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Naproxen<\/td>\n | Tablets<\/td>\n | 500mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Norethisterone<\/td>\n | Tablets<\/td>\n | 5mg<\/td>\n | 30 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Nortriptyline <\/td>\n | Tablets<\/td>\n | 10mg<\/td>\n | 100 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Nortriptyline <\/td>\n | Tablets<\/td>\n | 25mg<\/td>\n | 100 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Nortriptyline <\/td>\n | Tablets<\/td>\n | 50mg<\/td>\n | 30 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Oxycodone <\/span>(Sugar Free) <\/span><\/td>\n | Oral Solution <\/td>\n | 5mg\/5ml<\/td>\n | 250ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Oxycodone <\/span>(Sugar Free) <\/span><\/td>\n | Oral Solution <\/td>\n | 10mg\/1ml<\/td>\n | 120ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Oxycodone Injection <\/td>\n | Ampoules<\/td>\n | 10mg\/1ml<\/td>\n | 5<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Oxycodone Injection <\/td>\n | Ampoules<\/td>\n | 20mg\/2ml<\/td>\n | 5<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Oxycodone Solution for Injection of Infusion<\/td>\n | Ampoules<\/td>\n | 50mg\/1ml<\/td>\n | 5<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Oxytocin Concentrate for Solution for Infusion<\/td>\n | Ampoules<\/td>\n | 10IU\/1ml<\/td>\n | 5<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Paracetamol<\/td>\n | Caplets<\/td>\n | 500mg<\/td>\n | 12×16 Bli Pack<\/td>\n | GSL Generics<\/td>\n <\/tr>\n | Paracetamol Extra Strength <\/span>(500mg paracetamol, 65mg caffeine)<\/span><\/td>\n | Tablets<\/td>\n | 500mg\/65mg<\/td>\n | 12×16 Bli Pack<\/td>\n | GSL Generics<\/td>\n <\/tr>\n | Piperacillin\/Tazobactam<\/td>\n | Vial<\/td>\n | 4g\/0.5g<\/td>\n | 1<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Prednisolone<\/td>\n | Tablets<\/td>\n | 1mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Prednisolone<\/td>\n | Tablets<\/td>\n | 5mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Propylthiouracil<\/td>\n | Tablets<\/td>\n | 50mg<\/td>\n | 56 Pot<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Propylthiouracil<\/td>\n | Tablets<\/td>\n | 50mg<\/td>\n | 100 Pot<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Protamine Sulphate solution for injection <\/td>\n | Ampoules BP <\/td>\n | 50mg\/5ml<\/td>\n | 10 x 5ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Pyridoxine <\/td>\n | Tablets<\/td>\n | 50mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Ramipril<\/td>\n | Hard capsules<\/td>\n | 1.25mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Ramipril<\/td>\n | Hard capsules<\/td>\n | 2.5mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Ramipril<\/td>\n | Hard capsules<\/td>\n | 5mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Ramipril<\/td>\n | Hard capsules<\/td>\n | 10mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Remifentanil Powder for Solution for Injection <\/td>\n | Vials<\/td>\n | 1mg<\/td>\n | 5<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Remifentanil Powder for Solution for Injection <\/td>\n | Vials<\/td>\n | 2mg<\/td>\n | 5<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Remifentanil Powder for Solution for Injection <\/td>\n | Vials<\/td>\n | 5mg<\/td>\n | 5<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Rivaroxaban<\/td>\n | Tablets<\/td>\n | 15mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Rivaroxaban<\/td>\n | Tablets<\/td>\n | 20mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Rivaroxaban<\/td>\n | Tablets<\/td>\n | 20mg<\/td>\n | 100 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Sodium Valproate <\/td>\n | GR tablets<\/td>\n | 200mg <\/td>\n | 30 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Sodium Valproate <\/td>\n | GR tablets<\/td>\n | 500mg<\/td>\n | 30 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Sodium Valproate <\/span>(Sugar Free)<\/span><\/td>\n | Bottle<\/td>\n | 200mg\/5ml<\/td>\n | 300ml<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Sodium Valproate Solution for Injection or Infusion<\/td>\n | Ampoules<\/td>\n | 400mg\/4ml<\/td>\n | 5<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Sugammadex Injection<\/td>\n | Vials<\/td>\n | 500mg in 5ml<\/td>\n | 10<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Sulfadiazine<\/td>\n | Tablets<\/td>\n | 500mg<\/td>\n | 56 Pot <\/td>\n | POM Generics<\/td>\n <\/tr>\n | Sulpiride<\/td>\n | Tablets<\/td>\n | 200mg<\/td>\n | 30 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Sulpiride<\/td>\n | Tablets<\/td>\n | 400mg<\/td>\n | 30 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Tamoxifen<\/td>\n | Tablets<\/td>\n | 10mg<\/td>\n | 30 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Tamoxifen<\/td>\n | Tablets<\/td>\n | 20mg<\/td>\n | 30 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Tamoxifen<\/td>\n | Tablets<\/td>\n | 40mg<\/td>\n | 30 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Ursodeoxycholic acid <\/td>\n | Tablets<\/td>\n | 300mg<\/td>\n | 60 Bli.Pack<\/td>\n | POM Generics<\/td>\n <\/tr>\n | Acidex Advance (sodium alginate, potassium hydrogen carbonate)<\/td>\n | Aniseed <\/span>Oral Suspension<\/span><\/td>\n | <\/td>\n | 250ml<\/td>\n | P Retail Brand<\/td>\n <\/tr>\n | Acidex Advance <\/span>(sodium alginate, potassium hydrogen carbonate)<\/span><\/td>\n | Aniseed <\/span>Oral Suspension<\/span><\/td>\n | <\/td>\n | 500ml<\/td>\n | P Retail Brand<\/td>\n <\/tr>\n | Acidex Advance <\/span>(sodium alginate, potassium hydrogen carbonate)<\/span><\/td>\n | Peppermint <\/span>Oral Suspension<\/span><\/td>\n | <\/td>\n | 250ml<\/td>\n | P Retail Brand<\/td>\n <\/tr>\n | Acidex Advance <\/span>(sodium alginate, potassium hydrogen carbonate)<\/span><\/td>\n | Peppermint <\/span>Oral Suspension<\/span><\/td>\n | <\/td>\n | 500ml<\/td>\n | P Retail Brand<\/td>\n <\/tr>\n | Oxeltra\u00ae<\/sup><\/span> (Oxycodone hydrochloride)<\/span><\/td>\n | PR tablets<\/td>\n | 5mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM (CD) Retail Brand<\/td>\n <\/tr>\n | Oxeltra\u00ae<\/sup><\/span> (Oxycodone hydrochloride)<\/span><\/td>\n | PR tablets<\/td>\n | 10mg<\/td>\n | 56 Bli.Pack<\/td>\n | POM (CD) Retail Brand<\/td>\n <\/tr>\n | Oxeltra\u00ae<\/sup><\/span> (Oxycodone hydrochloride)<\/span><\/td>\n | PR tablets<\/td>\n | 15mg<\/td>\n | 56 Bli.Pack<\/td>\n | POM (CD) Retail Brand<\/td>\n <\/tr>\n | Oxeltra\u00ae<\/sup><\/span> (Oxycodone hydrochloride)<\/span><\/td>\n | PR tablets<\/td>\n | 20mg<\/td>\n | 56 Bli.Pack<\/td>\n | POM (CD) Retail Brand<\/td>\n <\/tr>\n | Oxeltra\u00ae<\/sup><\/span> (Oxycodone hydrochloride)<\/span><\/td>\n | PR tablets<\/td>\n | 30mg<\/td>\n | 56 Bli.Pack<\/td>\n | POM (CD) Retail Brand<\/td>\n <\/tr>\n | Oxeltra\u00ae<\/sup><\/span> (Oxycodone hydrochloride)<\/span><\/td>\n | PR tablets<\/td>\n | 40mg<\/td>\n | 56 Bli.Pack<\/td>\n | POM (CD) Retail Brand<\/td>\n <\/tr>\n | Oxeltra\u00ae<\/sup><\/span> (Oxycodone hydrochloride)<\/span><\/td>\n | PR tablets<\/td>\n | 60mg<\/td>\n | 56 Bli.Pack<\/td>\n | POM (CD) Retail Brand<\/td>\n <\/tr>\n | Oxeltra\u00ae<\/sup> (Oxycodone hydrochloride)<\/td>\n | PR tablets<\/td>\n | 80mg<\/td>\n | 56 Bli.Pack<\/td>\n | POM (CD) Retail Brand<\/td>\n <\/tr>\n | Budesonide\/formoterol (branded as WockAIR\u00ae<\/sup>)<\/b><\/td>\n | Inhalation device<\/td>\n | 160mcg\/4.5mcg<\/td>\n | 120 dose (2 x 60 dose inhaler multipack)<\/td>\n | POM Retail Brands<\/td>\n <\/tr>\n | Budesonide\/formoterol (branded as WockAIR\u00ae<\/sup>)<\/td>\n | Inhalation device<\/td>\n | 320mcg\/9mcg<\/td>\n | 60 dose (1 x 60 dose inhaler)<\/td>\n | POM Retail Brands<\/td>\n <\/tr>\n | Yaltormin SR (Metformin hydrochloride)<\/td>\n | PR tablets<\/td>\n | 500mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Retail Brand<\/td>\n <\/tr>\n | Yaltormin SR (Metformin hydrochloride)<\/td>\n | PR tablets<\/td>\n | 500mg<\/td>\n | 56 Bli.Pack<\/td>\n | POM Retail Brand<\/td>\n <\/tr>\n | Yaltormin SR (Metformin hydrochloride)<\/td>\n | PR tablets<\/td>\n | 750mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Retail Brand<\/td>\n <\/tr>\n | Yaltormin SR (Metformin hydrochloride)<\/td>\n | PR tablets<\/td>\n | 750mg<\/td>\n | 56 Bli.Pack<\/td>\n | POM Retail Brand<\/td>\n <\/tr>\n | Yaltormin SR (Metformin hydrochloride)<\/td>\n | PR tablets<\/td>\n | 1000mg<\/td>\n | 28 Bli.Pack<\/td>\n | POM Retail Brand<\/td>\n <\/tr>\n | Yaltormin SR (Metformin hydrochloride)<\/td>\n | PR tablets<\/td>\n | 1000mg<\/td>\n | 56 Bli.Pack<\/td>\n | POM Retail Brand<\/td>\n <\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":" | UK Product Name Formulation Strength Pack Size Product Classification Abiraterone Tablets 500mg 56 Bli.Pack POM Generics Aciclovir Tablets 200mg 25 Bli.Pack POM Generics Aciclovir Tablets 400mg 56 Bli.Pack POM Generics Aciclovir Tablets 800mg 35 Bli.Pack POM Generics Aciclovir powder for injection Vials 250mg 5 POM Generics Adenosine Injection Vials 6mg\/2ml 6 POM Generics Adenosine Injection … <\/p>\n |